267 related articles for article (PubMed ID: 7531964)
1. [GM-CSF.G-CSF].
Kitamura K
Gan To Kagaku Ryoho; 1995 Feb; 22(2):301-5. PubMed ID: 7531964
[TBL] [Abstract][Full Text] [Related]
2. The promise of colony-stimulating factors in clinical practice.
Glaspy JA; Ambersley JM
Oncol Nurs Forum; 1990; 17(1 Suppl):20-4. PubMed ID: 1689043
[TBL] [Abstract][Full Text] [Related]
3. [Hematopoietic growth factors in primary and therapy-related bone marrow insufficiency].
Hansen B; Hippe E; Jacobsen GK; Johnsen HE
Ugeskr Laeger; 1992 Jun; 154(24):1697-702. PubMed ID: 1378668
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
5. Haemopoietic growth factors--from discovery to clinical application.
Begley CG
Med J Malaysia; 1993 Mar; 48(1):3-8. PubMed ID: 7688062
[TBL] [Abstract][Full Text] [Related]
6. [Myeloid hemopoietic growth factors. Therapeutic possibilities and clinical experiences].
Hansen B; Johnsen HE
Ugeskr Laeger; 1990 Oct; 152(44):3232-7. PubMed ID: 1700524
[TBL] [Abstract][Full Text] [Related]
7. [Clinical use of granulocyte colony stimulating-factors (GM-CSF and G-CSF].
Borota R; Borota J; Belić A; Gebauer E; Stefanović N
Med Pregl; 1997; 50(3-4):87-93. PubMed ID: 9229690
[TBL] [Abstract][Full Text] [Related]
8. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
Vose JM; Bierman PJ; Ruby E; Reed EC; Bishop MR; Tarantolo S; Kessinger A; Armitage JO
Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo.
Gutschalk CM; Herold-Mende CC; Fusenig NE; Mueller MM
Cancer Res; 2006 Aug; 66(16):8026-36. PubMed ID: 16912178
[TBL] [Abstract][Full Text] [Related]
10. Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells.
Obermueller E; Vosseler S; Fusenig NE; Mueller MM
Cancer Res; 2004 Nov; 64(21):7801-12. PubMed ID: 15520186
[TBL] [Abstract][Full Text] [Related]
11. In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia.
Bacigalupo A; Piaggio G; Podestá M; Raffo MR; Tedone E; Sogno G; Benvenuto F; Figari O; Grassia L; Bagnara GP
Stem Cells; 1993 Jul; 11 Suppl 2():175-9. PubMed ID: 7691324
[TBL] [Abstract][Full Text] [Related]
12. G-CSF and the management of clozapine-induced agranulocytosis.
Gerson SL
J Clin Psychiatry; 1994 Sep; 55 Suppl B():139-42. PubMed ID: 7525542
[TBL] [Abstract][Full Text] [Related]
13. G-CSF and GM-CSF in clinical trials.
Antman KH
Yale J Biol Med; 1990; 63(5):387-410. PubMed ID: 1705737
[TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
15. Southwestern Internal Medicine Conference: clinical use of hematopoietic growth factors.
Fleischman RA
Am J Med Sci; 1993 Apr; 305(4):248-73. PubMed ID: 7682752
[TBL] [Abstract][Full Text] [Related]
16. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
17. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
Meng FY; Xu B; Sun J; Yang Y; Niu JN
Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):1051-2. PubMed ID: 15447861
[TBL] [Abstract][Full Text] [Related]
18. Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials.
Nissen-Druey C
Nouv Rev Fr Hematol (1978); 1989; 31(2):99-101. PubMed ID: 2475852
[No Abstract] [Full Text] [Related]
19. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
McCrady CW; Li F; Pettit GR; Grant S
Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
[TBL] [Abstract][Full Text] [Related]
20. The application of hematopoietic growth factors in drug-induced agranulocytosis: a review of 70 cases.
Sprikkelman A; de Wolf JT; Vellenga E
Leukemia; 1994 Dec; 8(12):2031-6. PubMed ID: 7528854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
